Bio-inspired optimization algorithms for smart antennas

This thesis studies the effectiveness of bio-inspired optimization algorithms in controlling adaptive antenna arrays. Smart antennas are able to automatically extract the desired signal from interferer signals and external noise. The angular pattern depends on the number of antenna elements, their geometrical arrangement, and their relative amplitude and phases. In the present work different antenna geometries are tested and compared when their array weights are optimized by different techniques. First, the Genetic Algorithm and Particle Swarm Optimization algorithms are used to find the best set of phases between antenna elements to obtain a desired antenna pattern. This pattern must meet several restraints, for example: Maximizing the power of the main lobe at a desired direction while keeping nulls towards interferers. A series of experiments show that the PSO achieves better and more consistent radiation patterns than the GA in terms of the total area of the antenna pattern. A second set of experiments use the Signal-to-Interference-plus-Noise-Ratio as the fitness function of optimization algorithms to find the array weights that configure a rectangular array. The results suggest an advantage in performance by reducing the number of iterations taken by the PSO, thus lowering the computational cost. During the development of this thesis, it was found that the initial states and particular parameters of the optimization algorithms affected their overall outcome. The third part of this work deals with the meta-optimization of these parameters to achieve the best results independently from particular initial parameters. Four algorithms were studied: Genetic Algorithm, Particle Swarm Optimization, Simulated Annealing and Hill Climb. It was found that the meta-optimization algorithms Local Unimodal Sampling and Pattern Search performed better to set the initial parameters and obtain the best performance of the bio-inspired methods studied

Tendencias y perspectivas de la produccion y consumo de la leche y productos derivados en Chile

Resumen (Spanish, English)93 p.El presente estudio tiene por objetivo analizar el mercado nacional de la leche y productos lácteos, el que está determinado por la oferta de los productores y demanda de los consumidores. En cuanto a la oferta lechera, la producción nacional, recepción en plantas y la elaboración de productos lácteos han crecido durante los años 1979 a 1998, y se espera que sigan creciendo hasta el año 2015, cuando la producción interna sería cerca de un 130% mayor a la de 1998. En relación a los precios reales pagados al productor lechero, éstos disminuyeron en el decenio 1989-98, ocurriendo lo mismo con los precios nacionales al por mayor y al detalle de la leche en polvo; en cambio, los precios nacionales de la leche fluida aumentaron al igual que los precios internacionales de la leche en polvo. En general, al año 2015 se espera que todos los precios aumenten en un 38,8% a partir de1998, debido a las tendencias de los precios internacionales, ya que se obtuvo una alta correlación entre ellos. La demanda de leche y productos lácteos tuvo una tendencia creciente; salvo en el caso de la leche condensada, debido a los cambios de hábitos alimenticios de las personas; proyectandose la misma tendencia para los años futuros estudiados. Expresado en leche fluida , el consumo per cápita crecería cerca de 146% entre 1998 y el año 2015 El principal canal de comercialización del productor son las plantas lecheras (69%), las cuales a su vez venden a los supermercados (60%), a industrias de alimentos (6%), instituciones varias (11%) y a otros detallisas (8%). En relación a los márgenes de precios del total de productos lácteos y a su evolución entre los promedios 1979-88 y 1989-98, las plantas lecheras representa entre un 58 a 59% del margen total, seguido por el margen de los detallistas (29 a 30%) y luego el de los agricultores (11%). En el último decenio (198998), el margen de precios promedio aumentó levemente respecto en el sector detallista del mercado; pero disminuyeron un poco en los casos del margen del agricultor y de las plantas lecheras. Respecto a los márgenes de precios de los productos lácteos principales, los márgenes de las plantas lecheras siempre han sido los más altos (54 a 86%), excepto en el caso de la leche fluida (34,5%) en el decenio 1979-88. Los márgenes de precios de los detallistas se ubican en una posición intermedia (21 a 43%), salvo en el caso de la leche condensada (2,65%) y el de la leche fluida ( 19,4%) en este último decenio. El margen de precios de los agricultores ha sido siempre el más bajo, con un rango de 3,63 a 3,74% en el caso de los quesos y hasta un 35,28 a 36,20% en la leche fluida

Height and body-mass index trajectories of school-aged children and adolescents from 1985 to 2019 in 200 countries and territories: a pooled analysis of 2181 population-based studies with 65 million participants

Summary Background Comparable global data on health and nutrition of school-aged children and adolescents are scarce. We aimed to estimate age trajectories and time trends in mean height and mean body-mass index (BMI), which measures weight gain beyond what is expected from height gain, for school-aged children and adolescents. Methods For this pooled analysis, we used a database of cardiometabolic risk factors collated by the Non-Communicable Disease Risk Factor Collaboration. We applied a Bayesian hierarchical model to estimate trends from 1985 to 2019 in mean height and mean BMI in 1-year age groups for ages 5–19 years. The model allowed for non-linear changes over time in mean height and mean BMI and for non-linear changes with age of children and adolescents, including periods of rapid growth during adolescence. Findings We pooled data from 2181 population-based studies, with measurements of height and weight in 65 million participants in 200 countries and territories. In 2019, we estimated a difference of 20 cm or higher in mean height of 19-year-old adolescents between countries with the tallest populations (the Netherlands, Montenegro, Estonia, and Bosnia and Herzegovina for boys; and the Netherlands, Montenegro, Denmark, and Iceland for girls) and those with the shortest populations (Timor-Leste, Laos, Solomon Islands, and Papua New Guinea for boys; and Guatemala, Bangladesh, Nepal, and Timor-Leste for girls). In the same year, the difference between the highest mean BMI (in Pacific island countries, Kuwait, Bahrain, The Bahamas, Chile, the USA, and New Zealand for both boys and girls and in South Africa for girls) and lowest mean BMI (in India, Bangladesh, Timor-Leste, Ethiopia, and Chad for boys and girls; and in Japan and Romania for girls) was approximately 9–10 kg/m2. In some countries, children aged 5 years started with healthier height or BMI than the global median and, in some cases, as healthy as the best performing countries, but they became progressively less healthy compared with their comparators as they grew older by not growing as tall (eg, boys in Austria and Barbados, and girls in Belgium and Puerto Rico) or gaining too much weight for their height (eg, girls and boys in Kuwait, Bahrain, Fiji, Jamaica, and Mexico; and girls in South Africa and New Zealand). In other countries, growing children overtook the height of their comparators (eg, Latvia, Czech Republic, Morocco, and Iran) or curbed their weight gain (eg, Italy, France, and Croatia) in late childhood and adolescence. When changes in both height and BMI were considered, girls in South Korea, Vietnam, Saudi Arabia, Turkey, and some central Asian countries (eg, Armenia and Azerbaijan), and boys in central and western Europe (eg, Portugal, Denmark, Poland, and Montenegro) had the healthiest changes in anthropometric status over the past 3·5 decades because, compared with children and adolescents in other countries, they had a much larger gain in height than they did in BMI. The unhealthiest changes—gaining too little height, too much weight for their height compared with children in other countries, or both—occurred in many countries in sub-Saharan Africa, New Zealand, and the USA for boys and girls; in Malaysia and some Pacific island nations for boys; and in Mexico for girls. Interpretation The height and BMI trajectories over age and time of school-aged children and adolescents are highly variable across countries, which indicates heterogeneous nutritional quality and lifelong health advantages and risks

Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants.

BACKGROUND: Hypertension can be detected at the primary health-care level and low-cost treatments can effectively control hypertension. We aimed to measure the prevalence of hypertension and progress in its detection, treatment, and control from 1990 to 2019 for 200 countries and territories. METHODS: We used data from 1990 to 2019 on people aged 30-79 years from population-representative studies with measurement of blood pressure and data on blood pressure treatment. We defined hypertension as having systolic blood pressure 140 mm Hg or greater, diastolic blood pressure 90 mm Hg or greater, or taking medication for hypertension. We applied a Bayesian hierarchical model to estimate the prevalence of hypertension and the proportion of people with hypertension who had a previous diagnosis (detection), who were taking medication for hypertension (treatment), and whose hypertension was controlled to below 140/90 mm Hg (control). The model allowed for trends over time to be non-linear and to vary by age. FINDINGS: The number of people aged 30-79 years with hypertension doubled from 1990 to 2019, from 331 (95% credible interval 306-359) million women and 317 (292-344) million men in 1990 to 626 (584-668) million women and 652 (604-698) million men in 2019, despite stable global age-standardised prevalence. In 2019, age-standardised hypertension prevalence was lowest in Canada and Peru for both men and women; in Taiwan, South Korea, Japan, and some countries in western Europe including Switzerland, Spain, and the UK for women; and in several low-income and middle-income countries such as Eritrea, Bangladesh, Ethiopia, and Solomon Islands for men. Hypertension prevalence surpassed 50% for women in two countries and men in nine countries, in central and eastern Europe, central Asia, Oceania, and Latin America. Globally, 59% (55-62) of women and 49% (46-52) of men with hypertension reported a previous diagnosis of hypertension in 2019, and 47% (43-51) of women and 38% (35-41) of men were treated. Control rates among people with hypertension in 2019 were 23% (20-27) for women and 18% (16-21) for men. In 2019, treatment and control rates were highest in South Korea, Canada, and Iceland (treatment >70%; control >50%), followed by the USA, Costa Rica, Germany, Portugal, and Taiwan. Treatment rates were less than 25% for women and less than 20% for men in Nepal, Indonesia, and some countries in sub-Saharan Africa and Oceania. Control rates were below 10% for women and men in these countries and for men in some countries in north Africa, central and south Asia, and eastern Europe. Treatment and control rates have improved in most countries since 1990, but we found little change in most countries in sub-Saharan Africa and Oceania. Improvements were largest in high-income countries, central Europe, and some upper-middle-income and recently high-income countries including Costa Rica, Taiwan, Kazakhstan, South Africa, Brazil, Chile, Turkey, and Iran. INTERPRETATION: Improvements in the detection, treatment, and control of hypertension have varied substantially across countries, with some middle-income countries now outperforming most high-income nations. The dual approach of reducing hypertension prevalence through primary prevention and enhancing its treatment and control is achievable not only in high-income countries but also in low-income and middle-income settings. FUNDING: WHO

Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants

Background Hypertension can be detected at the primary health-care level and low-cost treatments can effectively control hypertension. We aimed to measure the prevalence of hypertension and progress in its detection, treatment, and control from 1990 to 2019 for 200 countries and territories. Methods We used data from 1990 to 2019 on people aged 30-79 years from population-representative studies with measurement of blood pressure and data on blood pressure treatment. We defined hypertension as having systolic blood pressure 140 mm Hg or greater, diastolic blood pressure 90 mm Hg or greater, or taking medication for hypertension. We applied a Bayesian hierarchical model to estimate the prevalence of hypertension and the proportion of people with hypertension who had a previous diagnosis (detection), who were taking medication for hypertension (treatment), and whose hypertension was controlled to below 140/90 mm Hg (control). The model allowed for trends over time to be non-linear and to vary by age. Findings The number of people aged 30-79 years with hypertension doubled from 1990 to 2019, from 331 (95% credible interval 306-359) million women and 317 (292-344) million men in 1990 to 626 (584-668) million women and 652 (604-698) million men in 2019, despite stable global age-standardised prevalence. In 2019, age-standardised hypertension prevalence was lowest in Canada and Peru for both men and women; in Taiwan, South Korea, Japan, and some countries in western Europe including Switzerland, Spain, and the UK for women; and in several low-income and middle-income countries such as Eritrea, Bangladesh, Ethiopia, and Solomon Islands for men. Hypertension prevalence surpassed 50% for women in two countries and men in nine countries, in central and eastern Europe, central Asia, Oceania, and Latin America. Globally, 59% (55-62) of women and 49% (46-52) of men with hypertension reported a previous diagnosis of hypertension in 2019, and 47% (43-51) of women and 38% (35-41) of men were treated. Control rates among people with hypertension in 2019 were 23% (20-27) for women and 18% (16-21) for men. In 2019, treatment and control rates were highest in South Korea, Canada, and Iceland (treatment >70%; control >50%), followed by the USA, Costa Rica, Germany, Portugal, and Taiwan. Treatment rates were less than 25% for women and less than 20% for men in Nepal, Indonesia, and some countries in sub-Saharan Africa and Oceania. Control rates were below 10% for women and men in these countries and for men in some countries in north Africa, central and south Asia, and eastern Europe. Treatment and control rates have improved in most countries since 1990, but we found little change in most countries in sub-Saharan Africa and Oceania. Improvements were largest in high-income countries, central Europe, and some upper-middle-income and recently high-income countries including Costa Rica, Taiwan, Kazakhstan, South Africa, Brazil, Chile, Turkey, and Iran. Interpretation Improvements in the detection, treatment, and control of hypertension have varied substantially across countries, with some middle-income countries now outperforming most high-income nations. The dual approach of reducing hypertension prevalence through primary prevention and enhancing its treatment and control is achievable not only in high-income countries but also in low-income and middle-income settings. Copyright (C) 2021 World Health Organization; licensee Elsevier

Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants

Background Hypertension can be detected at the primary health-care level and low-cost treatments can effectively control hypertension. We aimed to measure the prevalence of hypertension and progress in its detection, treatment, and control from 1990 to 2019 for 200 countries and territories. Methods We used data from 1990 to 2019 on people aged 30–79 years from population-representative studies with measurement of blood pressure and data on blood pressure treatment. We defined hypertension as having systolic blood pressure 140 mm Hg or greater, diastolic blood pressure 90 mm Hg or greater, or taking medication for hypertension. We applied a Bayesian hierarchical model to estimate the prevalence of hypertension and the proportion of people with hypertension who had a previous diagnosis (detection), who were taking medication for hypertension (treatment), and whose hypertension was controlled to below 140/90 mm Hg (control). The model allowed for trends over time to be non-linear and to vary by age. Findings The number of people aged 30–79 years with hypertension doubled from 1990 to 2019, from 331 (95% credible interval 306–359) million women and 317 (292–344) million men in 1990 to 626 (584–668) million women and 652 (604–698) million men in 2019, despite stable global age-standardised prevalence. In 2019, age-standardised hypertension prevalence was lowest in Canada and Peru for both men and women; in Taiwan, South Korea, Japan, and some countries in western Europe including Switzerland, Spain, and the UK for women; and in several low-income and middle-income countries such as Eritrea, Bangladesh, Ethiopia, and Solomon Islands for men. Hypertension prevalence surpassed 50% for women in two countries and men in nine countries, in central and eastern Europe, central Asia, Oceania, and Latin America. Globally, 59% (55–62) of women and 49% (46–52) of men with hypertension reported a previous diagnosis of hypertension in 2019, and 47% (43–51) of women and 38% (35–41) of men were treated. Control rates among people with hypertension in 2019 were 23% (20–27) for women and 18% (16–21) for men. In 2019, treatment and control rates were highest in South Korea, Canada, and Iceland (treatment >70%; control >50%), followed by the USA, Costa Rica, Germany, Portugal, and Taiwan. Treatment rates were less than 25% for women and less than 20% for men in Nepal, Indonesia, and some countries in sub-Saharan Africa and Oceania. Control rates were below 10% for women and men in these countries and for men in some countries in north Africa, central and south Asia, and eastern Europe. Treatment and control rates have improved in most countries since 1990, but we found little change in most countries in sub-Saharan Africa and Oceania. Improvements were largest in high-income countries, central Europe, and some upper-middle-income and recently high-income countries including Costa Rica, Taiwan, Kazakhstan, South Africa, Brazil, Chile, Turkey, and Iran. Interpretation Improvements in the detection, treatment, and control of hypertension have varied substantially across countries, with some middle-income countries now outperforming most high-income nations. The dual approach of reducing hypertension prevalence through primary prevention and enhancing its treatment and control is achievable not only in high-income countries but also in low-income and middle-income settings

Bio-inspired optimization algorithms for smart antennas

This thesis studies the effectiveness of bio-inspired optimization algorithms in controlling adaptive antenna arrays. Smart antennas are able to automatically extract the desired signal from interferer signals and external noise. The angular pattern depends on the number of antenna elements, their geometrical arrangement, and their relative amplitude and phases. In the present work different antenna geometries are tested and compared when their array weights are optimized by different techniques. First, the Genetic Algorithm and Particle Swarm Optimization algorithms are used to find the best set of phases between antenna elements to obtain a desired antenna pattern. This pattern must meet several restraints, for example: Maximizing the power of the main lobe at a desired direction while keeping nulls towards interferers. A series of experiments show that the PSO achieves better and more consistent radiation patterns than the GA in terms of the total area of the antenna pattern. A second set of experiments use the Signal-to-Interference-plus-Noise-Ratio as the fitness function of optimization algorithms to find the array weights that configure a rectangular array. The results suggest an advantage in performance by reducing the number of iterations taken by the PSO, thus lowering the computational cost. During the development of this thesis, it was found that the initial states and particular parameters of the optimization algorithms affected their overall outcome. The third part of this work deals with the meta-optimization of these parameters to achieve the best results independently from particular initial parameters. Four algorithms were studied: Genetic Algorithm, Particle Swarm Optimization, Simulated Annealing and Hill Climb. It was found that the meta-optimization algorithms Local Unimodal Sampling and Pattern Search performed better to set the initial parameters and obtain the best performance of the bio-inspired methods studied.EThOS - Electronic Theses Online ServiceGBUnited Kingdo

Uniform Circular Arrays for Phased Array Antenna

This paper compares the performances of a number of uniform circular array (UCA) configurations for phased array antennas. A UCA geometry is targeted due to its symmetrical configuration which enables the phased array antenna to scan azimuthally with minimal changes in its beam width and sidelobe levels. Each UCA configuration consists of 19 isotropic elements. Particle Swarm Optimization (PSO) is used to calculate the complex weights of the antenna array elements in order to adapt the antenna to the changing environments. Comparisons are made in the context of adaptive beamforming properties and Signal to Interference Ratio (SIR). The results obtained suggest that a planar uniform hexagonal array PUHA (1:6:12) is suitable for high resolution applications as its sidelobe levels are the lowest compared to the other geometries

Factors Associated with SARS-CoV-2 Positivity in Patients Treated at the Lambayeque Regional Hospital, Peru during a Pandemic Period

The aim of this study was to provide additional data on mortality from COVID-19 with particular attention to the factors associated with the positivity of patients admitted to the Lambayeque Hospital in Peru. A retrospective cohort analysis was carried out to determine the clinical-epidemiological factors associated with positivity for SARS-CoV-2 in patients treated at the Lambayeque Regional Hospital during the health emergency period in the context of the COVID-19 pandemic. It was observed that, as the demographic age group increased, the percentage of seropositivity increased, with 66.8% of elderly adults testing positive, compared to 37.4% of children (p < 0.001). More seropositive men than women were evident (61.1% vs. 54.1%; p < 0.001). The most frequent symptom of patients with suspected COVID-19 was cough (65.0%). However, the symptoms with the greatest frequency of seropositive patients were ageusia (78.6%) and fever (77.6%); cough was one of the symptoms with the lowest (63.9%) (p-value < 0.001). The comorbidities with the most seropositive patients were obesity (80.7%) and diabetes mellitus (73.6%) (p-value < 0.001), different from the top comorbidity of heart disease (12.7%) in suspected COVID-19 patients. In terms of disease signs, abnormal findings on MRI (98.11%) and dyspnea (28.7%) were the most common in suspected COVID-19 patients, similar to those in seropositive patients, which were dyspnea (81.4%) and abnormal tomography findings (75.3%) (p-value < 0.001)